Multiple Myeloma, Daratumamab, Immunofixation

3003971
copy
 

Copy Utility


emailprint

Ordering Recommendation

Useful for monitoring treatment response and for assessing monoclonal antibody interference for patients with IgG kappa multiple myeloma being treated with daratumamab.

Mnemonic

MM DARA

Methodology

Qualitative Immunofixation Electrophoresis

Performed

Varies

Reported

4-9 days

New York DOH Approval Status

This test is New York DOH approved.

Specimen Required

Patient Preparation

Fasting specimen preferred.

Collect

Plain Red.

Specimen Preparation

Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 1 mL)
Test is not performed at ARUP; separate specimens must be submitted when multiple tests are ordered.

Storage/Transport Temperature

Refrigerated. Also acceptable: Room temperature or frozen.

Unacceptable Conditions
Remarks
Stability

Ambient: 5 days; Refrigerated: 6 days; Frozen: 6 months

Reference Interval

By report

Interpretive Data



Compliance Category

Note

Hotline History

View Hotline History

 

Hotline History

Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
08/16/2021
X
N/A

CPT Codes

86334

Are you an ARUP Client? Click here for your pricing.

Components

Component Test Code* Component Chart Name LOINC
3003972 Multiple Myeloma, Daratumumab, Interp 96420-5
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.

Aliases

  • DARA
  • Darzalex
Multiple Myeloma, Daratumamab, Immunofixation

Quest Diagnostics San Juan Capistrano Inc.